openPR Logo
Press release

Hormonal Contraceptives Market Size to Reach USD 26.6 billion at 5.8% CAGR Forecast 2021-2026

09-03-2021 10:19 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Hormonal Contraceptives Market Size to Reach USD 26.6 billion

The global “hormonal contraceptives market size” is projected to reach a value of USD 26.6 billion by 2026, with a notable CAGR of 5.8% during the forecast period 2019 to 2026. This is owing to the unmet needs for contraceptives worldwide, especially in developing nations. The market was valued at USD 16.7 billion in 2018. The World Health Organization estimated a rise in the utilization of modern contraceptives from 54% in 1990 to about 57.4% in 2015. This is attributable to the easy availability and user reliability of contraceptive products all over the world. Such factors are likely to add impetus to the hormonal contraceptives market size in the forecast duration.

Leading Players operating in the Latest Report Analysis Hormonal Contraceptives Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Piramal Enterprises Ltd
Novartis AG
Teva Pharmaceutical Industries
Janssen Pharmaceuticals, Inc.
Allergan
Merck & Co., Inc.
Pfizer, Inc.
Mylan N.V.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hormonal-contraceptives-market-102078

The report offers an elaborative analysis of numerous factors affecting the global Hormonal Contraceptives Market. These include opportunities, growth drivers, threats, key developments, and restraints. In addition to this, the report can further help in analyzing, segmenting, and defining the market based on different segments. It strategically analyzes several strategies such as product innovations, mergers, alliances, joint ventures, and acquisitions adopted by players in the industry.

Fortune Business Insights™ presents a comprehensive overview of the hormonal birth-control market in their recently published study titled, “Hormonal Contraceptives Market Size, Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026.”

Cost-efficiency and Easy Availability of Contraceptive Products to Promote Market Growth

The increasing cases of sexually transmitted diseases such as HIV/AIDS is a prime factor promoting the hormonal contraceptives market growth. Besides this, the cost efficiency and easy availability of contraceptives products such as pills, is also helping the market gain traction. Moreover, the fact that contraceptives are a better and reliable way of controlling unwanted pregnancy as compared to diaphragms/sponges or condoms is also expected to help increase the overall hormonal contraceptive market size in the forecast period.

Furthermore, the advent of new user-friendly and cost-efficient products into the market, such as contraceptive implants, vaginal rings, and injectable, are likely to help increase the overall hormonal birth control market revenue in the coming years.

Detailed Table of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Recent industry developments such as mergers & acquisitions
regulatory scenario for key countries
Fertility Statistics for Key Countries, 2018
Reimbursement Scenario
New Product Launches
Global Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis, Insights and Forecast – By Country
North America
Europe
Asia pacific
Latin America
Middle East & Africa
Global Hormonal Contraceptives Market Segmentation:

By Product

Pills
Injectable
Implants
Vaginal Ring
Intrauterine Devices
Others
By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
By Geography

North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East and Africa ( South Africa, GCC, and the Rest of Middle East & Africa)
Reasons to Purchase this Report:

Comprehensive analysis of the Hormonal Contraceptives Marketgrowth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hormonal-contraceptives-market-102078

KEY QUESTIONS ANSWERED:

What are the key technological and Hormonal Contraceptives Markettrends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Hormonal Contraceptives Marketgrowth?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormonal Contraceptives Market Size to Reach USD 26.6 billion at 5.8% CAGR Forecast 2021-2026 here

News-ID: 2379847 • Views: 88

More Releases from Fortune Business Insights Pvt. Ltd.

Key Companies Covered in the Connected Drug Delivery Devices Market Research Rep …
The global “connected drug delivery devices market size” is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights™, titled, “Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology
Key Companies Covered in the Hip Replacement Market Research Report are Raw mate …
The global hip replacement market size will increase with the advent of robot-assisted surgical procedures worldwide. Fortune Business Insights™ in their recent report titled, “Hip Replacement Market Size, Share & Industry Analysis, By Procedure (Total Hip Replacement, Partial Hip Replacement, and Revision & Hip Resurfacing), By End User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and Others) and Regional Forecast, 2019-2026”, provides a comprehensive analysis of the market and their
Key Companies Covered in the Gene Therapy Market Research Report are Novartis AG …
The global gene therapy market is set to gain momentum from the rising incidence of different types of cancer. The field of this therapy is undergoing several technological advancements that would help in treating cancer in those patients who are at high risks of getting affected by this disease through genetic mutations. Fortune Business Insights™ provided this information in a new report, titled, “Gene Therapy Market Size, Share & COVID-19
Medical Transcription Software Market Size and Detailed Analysis Focusing On Key …
The global medical transcription software market size will benefit from the growing penetration of technology and automation in several applications across the healthcare industry. According to a report published by Fortune Business Insights, titled “Medical Transcription Software Market Size, Share & Industry Analysis, By Deployment (Cloud/Web-based and Installed/On-Premises), By End User Facility (Hospitals, Diagnostic Centers, Clinics, and Others), By Type (Voice Capture and Voice Recognition), By End User (Radiologists, Surgeons,

All 5 Releases


More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the